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Abstract
Background: Traumatic brain injury (TBI) initiates a complex sequence of destructive and
neuroprotective cellular responses. The initial mechanical injury is followed by an extended time
period of secondary brain damage. Due to the complicated pathological picture a better
understanding of the molecular events occurring during this secondary phase of injury is needed.
This study was aimed at analysing gene expression patterns following cerebral cortical contusion in
rat using high throughput microarray technology with the goal of identifying genes involved in an
early and in a more delayed phase of trauma, as genomic responses behind secondary mechanisms
likely are time-dependent.
Results: Among the upregulated genes 1 day post injury, were transcription factors and genes
involved in metabolism, e.g. STAT-3, C/EBP-δ and cytochrome p450. At 4 days post injury we
observed increased gene expression of inflammatory factors, proteases and their inhibitors, like
cathepsins, α-2-macroglobulin and C1q. Notably, genes with biological function clustered to
immune response were significantly upregulated 4 days after injury, which was not found following
1 day. Osteopontin and one of its receptors, CD-44, were both upregulated showing a local
mRNA- and immunoreactivity pattern in and around the injury site. Fewer genes had decreased
expression both 1 and 4 days post injury and included genes implicated in transport, metabolism,
signalling, and extra cellular matrix formation, e.g. vitronectin, neuroserpin and angiotensinogen.
Conclusion: The different patterns of gene expression, with little overlap in genes, 1 and 4 days
post injury showed time dependence in genomic responses to trauma. An early induction of factors
involved in transcription could lead to the later inflammatory response with strongly upregulated
CD-44 and osteopontin expression. An increased knowledge of genes regulating the pathological
mechanisms in trauma will help to find future treatment targets. Since trauma is a risk factor for
development of neurodegenerative disease, this knowledge may also reduce late negative effects.
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Traumatic brain injury (TBI) is a complex disorder, often
with a severe or deadly outcome. The primary phase with
tissue disruption initiates secondary injury processes in a
delayed phase causing pathophysiological changes in the
brain. As a consequence of the initial mechanical impact
to the head, cerebral metabolism, blood flow and ion
homeostasis are altered for a period of hours to days and
even months [1]. During the secondary injury high levels
of glutamate, Ca2+ and lactate are released, and cytokines
are produced, leading to an inflammatory response,
which all contribute to further tissue damage [2]. Beside
the destructive processes, endogenous neuroprotective
events in repair and regeneration also occur [3]. However,
harmful processes dominate and eventually lead to tissue
loss due to cell death. A challenge lies in understanding
the molecular mechanisms behind the pathological proc-
esses, and the complex interplay between the different
genes and their pathways operating after TBI. Despite a
growing literature and extensive research on TBI, current
clinical treatments are insufficient to support the repair
processes and obstruct secondary injuries why preventive
measures might be the most efficient way to improve out-
comes.
The disrupted homeostasis in energy and oxygen supply
leads to activation of several systems. Transcription,
growth, plasticity, differentiation, signalling, inflamma-
tion, and cell death genes are affected in different trauma
models. The injury alters mRNA and/ or protein levels for
e.g. growth factors like NGF, BDNF, and the IGF system
[4,5], apoptotic and anti-apoptotic factors like caspases,
bax and bcl-2 [6,7], immediate early genes such as c-fos,
c-jun and JunB [8], inflammatory markers like interleuk-
ines [9] and heat shock proteins [10].
The microarray technique gives an opportunity to simul-
taneously look at gene expression changes in a large
number of genes. It is thus a means to cope with multiple
processes, which may well be a prerequisite to handle the
complexity of TBI. Trauma reports in mice and rat have
mainly focused on early time points around 2 – 72 hours
after trauma [11-17]. Later time-points after TBI have not
been studied in the rat, although late changes in mice
show similarities to those induced by ischaemia in rats
[18]. Genes operating at later time-points may well be
linked to the continuous brain tissue damage and second-
ary injuries, which develops after impact. As molecular
responses to trauma are time-dependent, we have com-
pared RNA expression after TBI in individual rats 1 and 4
days post injury (dpi). We used the weight-drop tech-
nique to produce a cerebral cortical contusion (CCC)
[19], which mimics the clinical situation of focal contu-
sion in patients. Alterations in RNA levels in the injured
cortex were compared to the uninjured cortex and ana-
lysed with a cDNA microarray containing 6200 probes.
We found more affected genes 1 dpi than 4 dpi with little
overlap existing between the two time points. Significant
differences between 1 and 4 dpi were seen in groups of
upregulated genes involved in e.g. transcription, metabo-
lism and cell proliferation. Genes involved in proteolysis
and immune responses were significantly overrepresented




A cDNA microarray containing 6200 gene probes was
used to study changes in gene expression induced by CCC
in the ipsilateral cortex (including site of injury) in com-
parison to the contralateral uninjured cortex. At 1 dpi, the
expression of 150 genes was significantly increased [see
Additional file 1] while 61 genes were downregulated [see
Additional file 2]. In contrast, 4 dpi displayed 56 upregu-
lated genes [see Additional file 1], while 7 were downreg-
ulated [see Additional file 2]. Only 20 genes were
upregulated both 1 and 4 dpi, while none of the downreg-
ulated genes were in common for the two time points
(Fig. 1).
Venn diagram illustrating regulated genes after cerebral corti-cal contusion 1 and 4 dpiFigure 1
Venn diagram illustrating regulated genes after cere-
bral cortical contusion 1 and 4 dpi. Overlapping area 
shows genes for which expression was altered at both time 
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functional classification proposed by the Gene Ontology
Consortia, to allow for analysis of the response 1 and 4
dpi. A comparison of frequency distribution between gene
ontology (GO) categories related to biological function,
between the whole set of expressed genes and upregulated
genes (Fig. 2), showed that both 1 and 4 dpi displayed a
significant overrepresentation (p < 0.05) of upregulated
genes in the categories 'cell differentiation'
(GO:0030154), 'cellular defence response'
(GO:0006968) and 'response to stimuli' (GO:0050896).
Additionally at 1 dpi, 'cell growth' (GO:0016049), 'trans-
port' (GO:0006810), 'development' (GO:0007275), 'cell
death' (GO:0008219) and 'regulation of cell cycle'
(GO:0000074) showed significant upregulation. Four
days post injury, significant upregulation of 'immune
response' (GO:0006955) and 'proteolysis and peptidoly-
sis' (GO:0006508) were observed. Comparing the groups
of downregulated genes to the whole set of expressed
genes resulted in no significant category with the fre-
quency distribution test, neither for 1 dpi nor 4 dpi. Other
regulated genes were found in most functional categories
indicating that response to injury is complex and affects
many different biological processes.
Next, we analysed if there were statistically significant dif-
ferences between the distributions of genes in functional
categories when comparing 1 and 4 dpi (Fig. 2). Signifi-
cantly (p < 0.05) different distribution of upregulated
genes among GO categories were detected for 'cell com-
munication' (GO:0009987), 'cell death' (GO:0008219),
'cell proliferation' (GO:0008283), 'metabolism'
(GO:0008152) and 'transcription' (GO:0006350) clearly
indicating the qualitative differences in response to
trauma at the two different time points. There were no sta-
tistical differences in the GO categories between downreg-
ulated genes comparing 1 and 4 dpi. However, only seven
genes were found to be downregulated at 4 dpi.
Functional classification of regulated genes 1 and 4 days after cerebral cortical contusionigure 2
Functional classification of regulated genes 1 and 4 days after cerebral cortical contusion. Up- and downregulated 
genes with fold changes >1.6 at a 2% false discovery rate, annotated and categorised by the gene ontology database eGOn. 
Note a significant (p < 0.05) overrepresentation of upregulated genes in relation to total number of expressed genes (*) in the 
functional groups of cell differentiation, defence response and response to stimulus, for both 1 and 4 days post injury (dpi), 
while 1 dpi also showed significance (p < 0.05) for genes involved in cell death, cell growth, cellular morphogenesis, develop-
ment, regulation of cell cycle and transport. Additionally, genes with increased expression showed significant difference (p < 
0.05) between 1 and 4 dpi in the groups of cell communication, cell death, cell proliferation, metabolism and transcription (¤) 
analysed by eGOn.
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BMC Neuroscience 2005, 6:69 http://www.biomedcentral.com/1471-2202/6/69Regulated genes were also grouped manually, without tak-
ing multiple functions for a gene in consideration. 'Tran-
scription and translation' was a large group at 1 dpi,
whereas at 4 dpi genes in the groups 'proteases and their
inhibitors' and 'ECM (extra cellular matrix) and cytoskel-
eton' were well represented [see Additional file 1]. Among
regulated genes with decreased expression, 'transporters,
channels and binding proteins' and 'metabolism' were
large groups at day 1 [see Additional file 2].
PCR, in situ hybridisation and immunohistochemistry
CD-44, osteopontin (Opn), TIMP-1 and -2 (tissue inhibi-
tors of matrix metalloproteinases), S-100 (injury marker),
angiotensinogen (precursor for angiotensin), insulin-like
growth factor (IGF)-II, and vitronectin were further ana-
lysed by PCR confirming genes as differentially expressed,
in line with the microarray results (Fig. 3). Among the set
of regulated genes, Opn and CD-44 have potentially
important regulatory roles in brain injury. CD-44 is a
receptor for Opn and interestingly, CD-44-/- mice are pro-
tected from ischaemia induced injury [20]. The fact that
both ligand and receptor are upregulated suggests a possi-
ble auto-/paracrine regulating loop at the site of the injury
involving these genes. To further explore these findings,
the expression of Opn and CD-44 were studied by in situ
hybridisation and immunohistochemistry. Opn mRNA
expression was confined to the injury site (Fig. 4) at both
1 and 4 dpi consistent with the microarray result. Its
immunoreactivity was co-localised to ED-1, a marker for
macrophages and activated microglia (Fig. 5). CD-44
showed a similar local mRNA expression pattern in the
damaged region (Fig. 4) with a matching immunoreactiv-
ity (Fig. 5) 4 dpi. Nuclear staining with Hoescht showed
cytoplasmatic CD-44 expression. Neither in situ hybridi-
sation nor immunohistochemistry revealed contralateral
expression for either CD-44 or Opn.
Discussion
In this study we have identified 211 genes that were regu-
lated at 1 dpi and 63 at 4 dpi following a mild focal exper-
imental contusion. The changes at 1 dpi were either
initiated by traumatic events that affected gene activation
directly, such as depolarisation and increase of intracellu-
lar calcium, or as a reaction to traumatically disrupted
membranes, ischaemia and increased metabolic
demands. At the early time-point, many genes involved in
metabolism were affected, such as lactate dehydrogenase
and PDH phosphate, which would increase the rate of
pyruvate utilisation. Likewise, genes involved in cell
growth, cellular morphogenesis, development, transport,
cell differentiation, cellular defence response and regula-
tion of cell cycle were significantly upregulated. This was
also the case for 'response to stimulus' genes, confirming
TBI as a strong inducer of genomic responses. Genes in
this group included early mediators such as hsp, Nfkb1,
p53; many of which have been identified upregulated pre-
viously in experimental trauma [21]. Activation of these
genes agrees well with the prevailing theories of response
to trauma: ictus leads to activation of reactions that
require energy while mitochondrial dysfunction may
limit aerobic metabolism.
It is maybe not surprising that more genes were regulated
at day 1 than day 4 after injury. Several of the early
responding genes were transcription factors with potential
to initiate further gene regulation. It is probable that early
responses were, to some extent, chaotic while 4 dpi find-
ings represented a situation with less ongoing reparative
and/or destructive cellular processes. It may be futile to
search for specific destructive pathways with a hope to
inhibit these in the early stages: broad gene activation may
be non-specific and reflect that the trauma-energy has
overcome the activation energy requirements for many
different reactions. Our experimental injury model, CCC,
creates a focal contusion lesion but does not cause major
neurological deficits, prolonged unconsciousness or
death, and is therefore considered a mild injury. The
experimental injury resembles clinical contusions in
patients who have a favourable condition early after
injury, but are at risk of deterioration from progression of
the focal contusions. This is a typical cause of patients
who "talk and die" [22], where energy transfer at the
impact has not been sufficient to destroy main vital func-
Confirmation of regulated genes after microarray analysisFigure 3
Confirmation of regulated genes after microarray 
analysis. Genes with altered expression analysed by reverse 
transcriptase-polymerase chain reaction (RT-PCR), compar-
ing ipsilateral (i) to contralateral (c) hemisphere. OPN – 
osteopontin, TIMP-1/-2 – tissue inhibitor of matrix metallo-
proteinase, PAT – angiotensinogen, IGF-II – insulin like 
growth factor – II, and VTN – vitronectin.Page 4 of 11
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neural function in a delayed manner. This is in line with
the observation that genes with a role in cell death were
markedly overrepresented at 1 dpi and differed signifi-
cantly from 4 dpi, which could initiate neuronal apopto-
sis that occurs for a prolonged time after injury in this
model [7].
Our study showed significant differences between 1 and 4
dpi for genes with increased expression involved in cell
communication, cell proliferation, metabolism and tran-
scription. However, similarly to 1 dpi, 4 dpi also displayed
significant upregulation of genes involved in cellular dif-
ferentiation and response to stimuli. An analysis of the
stimulus response 4 dpi showed significance in immune
response, which was not present at 1 dpi. The view of the
brain as immunologically privileged has been re-evalu-
ated during the last years. Neuroinflammation, either
acute in trauma or chronic in neurodegenerative diseases,
has been revealed as a pathological mechanism [23]. The
defence response in TBI could generate chronic harmful
stimuli resulting in neurodegeneration, while it also paves
the way for repair. The immune response is likely to be
involved in the secondary injury mechanisms working at
the later time point.
Opn, strongly upregulated both 1 and 4 dpi, is involved in
inflammation, formation of the ECM and cell-matrix
interactions. Opn modulates processes like mitochondrial
respiration [24] and nitric oxide inhibition [25], affected
in TBI. The diverse roles of Opn depend on receptor inter-
action and phosphorylation state [26]. Opn actions are
mediated by integrins and CD-44, a cell surface glycopro-
tein. Interestingly, CD-44 also showed increased expres-
sion levels at 4 dpi. As both Opn and CD-44 are involved
in inflammation and neurodegeneration [27] we chose to
study these molecules in more detail. Opn mRNA expres-
sion and immunoreactivity were confined to the injury
site, which co-localised with the macrophage and acti-
vated microglia marker ED-1. Opn can induce migration
of astrocytes in vitro, and has therefore been proposed as
an "astrokine" [28]. In our model this could mean that
macrophages attract astrocytes to the damaged area,
which would be in line with the above proposition. Fur-
thermore, Opn may contribute to the nonpermissive
adult CNS milieu, in the glial scar, and inhibiting axon
outgrowth [29]. CD-44 mRNA was found locally around
and in the lesion area 1 and 4 dpi. This has not been
reported previously in this experimental contusion
model, but agrees with CD-44 expression after cortical
incision in mice [30]. We saw a corresponding immuno-
reactivity, resembling Opn immunoreactivity, in the
penumbra and injured area, indicating interactions
between Opn and CD-44. Our findings corroborate stud-
ies of upregulated Opn and CD-44 expression in other
brain injury models [12,31]. Opn administration was
recently reported to be neuroprotective in stroke [32]
whereas increased CD-44 mRNA seems to be harmful in
ischaemia [20]. It is possible that Opn interacting with
CD-44 could activate a pathway leading to further injury,
while Opn-integrin interactions would confer neuropro-
tection. However, other genes affected following injury
may also influence the result of Opn expression.
Wound healing in the brain as in other injured tissues
requires synthesis of new ECM molecules. The upregula-
Localisation of CD-44 and osteopontin mRNA expressionFigure 4
Localisation of CD-44 and osteopontin mRNA expression. Autoradiographs following in situ hybridisation of rat brain 
sections after contusion showing CD-44 and OPN – osteopontin mRNA expression. Note intense mRNA signal in contusion 
area with no visible signal in contralateral hemisphere.Page 5 of 11
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reflect a temporary state with a new matrix, attempting to
create an environment more suitable for cell migration.
However, we also observed downregulation of vitronectin
expression. Vitronectin is an extracellular glycoprotein
[33], which could impair cell migration and attachment,
and may be necessary for a favourable cell environment.
ECM has more functions than mere structural support.
For many cell types, ECM acts as a survival factor as cells
deprived of matrix attachment are prone to die by apop-
tosis, and a distorted matrix network also may hinder
actions of trophic factors due to defective presentation.
Cell attachment generates intracellular signals ending in
regulation of cytoskeletal organisation and gene expres-
sion [34]. The bridging molecules ezrin and moesin,
which were upregulated 1 dpi, and 1 and 4 dpi respec-
tively, probably influence extracellular signals to the
cytoskeleton. A way to maintain homeostasis by stabilis-
ing the cytoskeleton, might be upregulation of the inter-
mediate filament vimentin (here increased 1 and 4 dpi).
Proteolytic enzymes cause structural ECM changes. Here,
CCC altered the expression of many genes for matrix- and
matrix modelling molecules reflected in the prominent
category 'proteolysis and peptidolysis' specifically at 4 dpi.
In this category we found cathepsins but also proteases
such as myelencephalon specific protease, which, to our
knowledge, is described regulated in this experimental
model for the first time. Though proteases are required for
re-organisation and plasticity in order to break down
obstructing debris, there might be an imbalance in expres-
sion between them and their inhibitors, like upregulation
of TIMP-1 and TIMP-2 mRNA, or downregulation of neu-
roserpin. Proteases challenge blood brain barrier (BBB)
function. The upregulated MMP-9 (matrix metalloprotei-
nase), involved in BBB breakdown [35], is one marker of
secondary injury processes. Further on, the precursor of
angiotensin, angiotensinogen, which is involved in BBB
reconstitution, was here downregulated 1 dpi [36].
Our experimental contusion resulted in altered mRNA
levels for genes in the category 'transcription response'
with significant differences between 1 and 4 dpi. Many
genes, among them ATF (activating transcription factor)-
4, rad (ras associated with diabetes) and retinoic acid
receptor, were upregulated at the early time-point, while
only a few genes remained altered at the later phase. A
novel finding here was the increased expression at 1 dpi of
CCAAT/enhancer binding protein (C/EBP)-δ belonging to
C/EBP (bZIP) family, which couples extracellular signal
transduction pathways to numerous cellular processes
and is a potential tumour suppressor gene [37]. Activated
C/EBP-δ regulates the neuroprotective IGF-1 [38] and
neurotoxic iNOS expression [39], both affected by TBI.
Fluorescence photomicrographs showing CD-44 and osteopontin immunoreactivity, 4 dpiigure 5
Fluorescence photomicrographs showing CD-44 and osteopontin immunoreactivity, 4 dpi. High-power photomi-
crographs of injured rat brains close to impact show immunofluorescence staining for CD-44 and osteopontin (OPN). Nuclear 
staining with Hoescht illustrates, in the merged picture, (CD-44/Hoescht) the cytoplasmatic staining for CD-44. Immunofluo-
rescence staining for ED-1, a macrophage marker, demonstrates, in the merged picture, (OPN/ED-1) co-localisation with oste-
opontin. Scale bar = 50 µm.Page 6 of 11
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involved in brain injury [40] and neuronal survival [41].
Moreover, C/EBP-β and -δ expression are upregulated by
inflammatory stimuli. It is therefore possible that C/EBP-
δ also would influence neuronal survival. Another regu-
lated transcription factor belonging to the immediate
early gene family was v-myc (homologue to c-myc). Myc
is a key molecular integrator of cell cycle machinery and
metabolism [42], and many of its target genes were seen
upregulated after CCC in this study. Prothymosin-α (PT-
α) is a c-myc target [43], associated with cell growth, tran-
scription [44] and recently also suggested to be involved
in apoptosis [45]. To our knowledge, we here show for the
first time that it's expression level is upregulated following
trauma. This knowledge combined with the fact that TBI
is a risk factor for neurodegernative disorders with exces-
sive cell death suggests that PT-α may well be a potential
candidate for further studies with regard to TBI. Recently,
PT-α was shown to associate with STAT-3, an acute phase
response factor, resulting in nuclear translocation [46]. In
this study increased STAT-3 mRNA levels were noted 1
dpi, corroborating other studies [15,29].
Microarray analyses create large amounts of data and
would ideally allow understanding of common regulatory
pathways. Database developments with possibilities to
better compare similarities and differences between vari-
ous experimental models will be advantageous when
forming new hypotheses. Whether the similarities or dif-
ferences between affected genes turn out to be the most
important factors is empirical: trauma needs to be studied
from all its angles.
Conclusion
This study of genomic responses to trauma comparing 1
dpi to 4 dpi showed significant time-dependent differ-
ences, such as the early response in the category 'transcrip-
tion response' and a more delayed response in the
category 'immune defence'. The upregulation of CD-44
and Opn, localised to injury site, probably have important
roles in the inflammatory process following TBI. Out-
come of their interaction needs to be further studied in
order to understand beneficial or detrimental roles.
Understanding the pathological mechanisms behind sec-
ondary insults and the interplay of operating genes, may
help to find treatment targets for brain injury and reduce




All studies were conducted in accordance with the guide-
lines of the regional ethics committee for animal research
at the Karolinska University Hospital, Stockholm, Swe-
den. Totally, 15 male Sprague Dawley rats (BW 250 g;
B&K Universal AB, Stockholm, Sweden) were included in
the study. Before surgery all rats were anaesthetised with
an intramuscular injection of 0.2 ml Hypnorm™ -Dormi-
kum (1:1:2; Hypnorm™ (fentanyl citrate 0.315 mg/ml,
fluanisone 10 mg/ml, Janssen Pharmaceutica, Beerse, Bel-
gium): Dormikum (1 mg/ml, Roche AB, Stockholm, Swe-
den): dH2O). Prior to the skin incision, 0.1 ml Xylocaine®
(5 mg/ml, Astra, Södertälje, Sweden) was injected subcu-
taneously in the sagittal midline of the skull and the rats
were placed in a stereotactic frame.
Cerebral cortical contusion
Contusions were performed on 13 rats using the weight-
drop model described by Feeney et al. [19]. In brief, a
craniotomy was made 2.5 mm posterior and 2.5 mm lat-
eral to bregma, and a footplate was placed so that it rested
upon the surface of the dura. A stainless tube guided a 24
g weight, which was dropped from a height of 9.3 cm,
compressing the tissue at a maximum of 3 mm. After
impact, the scalp was sutured and the animals were
allowed to recover. Sham operation, craniotomy without
contusion, was performed on two animals. The rats were
sacrificed at one day (n = 6) and four days (n = 9) by
decapitation in Hypnorm™ anaesthesia. Brains (1 dpi n =
3; 4 dpi n = 4) were removed, and impact area with sur-
rounding cortex, ipsilateral and contralateral was dis-
sected out, before quickly frozen in isopentan containing
dry ice, prior to RNA isolation. The remaining brains
(1dpi n = 3, 4 dpi n= 3, sham n = 2) were removed for sec-
tioning and directly frozen in isopentan – dry ice. Coronal
14 µm cryosections were cut through the center of the
impact using a Leica cryostat (CM 3000, Leica Instruments
GmbH, Nussloch, Germany). The sections were thaw-
mounted onto Super Frost/Plus™ object glasses (Menzel-
Gläser, Braunschweig, Germany) and stored at -20°C
prior to use.
RNA extraction
Total RNA was isolated using RNeasy Qiagen kit (VWR
International AB, Stockholm, Sweden) according to man-
ufacturer's protocol. Brain tissue was homogenised using
a polytron. The RNA was dissolved in diethyl pyrocar-
bonate (DEPC) treated dH2O and quantified by spectro-




The cDNA microarrays were described earlier [47] but
now extended to comprise about 6200 clones. Clones
were selected from the TIGR Rat gene Index [48], Research
Genetics [49] and from the lab obtained during differen-
tial cloning experiments. Arrays were pre-hybridised in
1% bovine serum albumin (BSA), 5 × SSC (1 × SSC: 0.15
M NaCl, 0.015 M sodium citrate) and 0.1% sodiumPage 7 of 11
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Gene Primer/oligonucleotide probe sequence (nts) Product (bp) Acc. no
PAT F: 5'-GAAGCTAGAGGCTGAGGATC- 3'
R: 5'-GTGCAGTCTCCCTCCTTCAC- 3'
233 L00091
S-100 F: 5'-GGACCTGAGAGTGCTCATGG- 3'
R: 5'-GCATGCAATGATGAGCCCCG-3'
222 J03627.1
IGF-II F: 5'-GACTGAGTTGGGGCAAATAC- 3'
R: 5'-CAGGTGTTAGGAAGGTGCTC- 3'
211 AA899788
CD-44 F: 5'-CCGACCTTCCCACTTCACAG- 3'
R: 5'-TCTCCTCGCAGGACCAGAAG- 3'
5'- ATCACTGGTGGCCAGGGTGCTCCCA ATAAAGAAGGCGTCATCCC-3' (44-mer)
200 AA817820













Nts = nucleotides, bp = base pairs, acc. no = accession number
dodecyl sulfate (SDS), at 42°C for 1–2 hours, washed in
milli-Q H2O and dried immediately before the probe was
applied.
cDNA labelling, purification, and hybridisation
Total RNA (30 µg) was used from individual animals in
each hybridisation. Labelled cDNA was produced using
an oligo-dT primer and Cy3-/ Cy5-uridine 5'-triphosphate
labelled nucleotides (PerkinElmer, MA) in reverse tran-
scription using Superscript II (Life Technologies Inc., NY).
Cy3- and Cy5-labelled cDNAs were pooled and purified
using Microcon 30 columns (Millipore, MA) and then
adjusted to a final volume of 25 µl with hybridisation
buffer [3.4 × SSC, 0.3% SDS, 20 µg mouse Cot-1 DNA
(Invitrogen, CA), 20 µg poly A RNA, 20 µg yeast tRNA].
After heating at 98°C for 2 min and cooling to room tem-
perature, the probe was added to the array and covered by
a plastic cover-slip, put in a sealed hybridisation chamber
(Corning Inc., NY), and hybridised at 65°C for 15–18
hours. Then the array was washed, dried and immediately
scanned with a GMS 418 scanner (Affymetrix, CA). Anal-
yses were made on individual animals and with dye-swap
to account for dye-biased effects; 1 dpi n= 3 (two animals
with ipsilateral total RNA labelled with Cy5 and one ani-
mal with ipsilateral total RNA labelled with Cy3) and 4
dpi n= 4 (two animals with ipsilateral total RNA labelled
with Cy5 and two with ipsilateral total RNA labelled with
Cy3).
Data processing and analysis
Image analysis was performed with GenePix Pro software
(Axon instruments, CA). Automatic and manual flagging
were used to localise absent or very weak spots (< 2 times
above background), which were excluded from analysis.
The signal from each spot was calculated as the average
intensity minus the average local background. Expression
ratios of Cy5/Cy3 (or Cy3/Cy5 in case of dye-swap) were
normalised using a method that takes into account and
corrects for intensity-dependent artefacts in the measure-
ments; the locally weighted linear regression (Lowess)
method in the SMA package (Statistics for Microarray
Analysis)[50,51]. SMA is an add-on library written in the
public domain statistical language R.
The significance of expression ratios was statistically eval-
uated using the SAM (Significance Analysis of Microar-
rays) technique [52]. Similarly to the familiar p-value, a q-
value was assigned each of the detectable genes in the
array. The q-value measures the lowest false discovery rate
(FDR) at which the gene is called significant. A 2% FDR
was used to identify regulated genes. On top of the SAM
criteria, a mean ratio cut off (log2 ratio injured/uninjured
> 0.7 corresponding to > 1.6-fold regulation) was applied
to describe ratios as up-/down-regulated and was applied
to each hybridised microarray. Using these settings one
could expect three genes falsely identified as regulated
among the 150 upregulated 1 dpi and one gene among
those identified 4 dpi. Data has been deposited in Gene
Expression Omnibus [53].
We used the web based tool eGOn v 1.0 (explore Gene
Ontology, developed at the Norwegian University of Sci-
ence and Technology) [54] to functionally classify the
transcripts. A total of 3414 genes 1 dpi and 2242 genes 4
dpi were deposited in eGOn of which 1272 genes for 1 dpi
and 904 genes for 4 dpi were annotated by eGOn and cat-Page 8 of 11
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biological function. Each list of differentially expressed
genes were compared to all genes expressed, for 1 respec-
tively 4 dpi with the two sided one-sample binomial test
implemented in eGOn. Comparison was made to test if
the proportion of genes upregulated at 1 dpi was different
from the proportion of genes upregulated 4 dpi, in eGOn,
which use McNemars test based on an implementation
using the binomial distribution. Additionally, also using
eGOn, upregulated genes were compared to downregu-
lated genes for 1 and 4 dpi separately with Fishers exact
test.
The regulated genes presented in tables 1 and 2 were
grouped based on information from Gene ontology,
DAVID (Database for Annotation and Visualisation and
Integrated Discovery) [55], PubMed and other existing
array reports. A gene can be annotated for several func-
tions, which is not displayed in the tables where a gene is
assigned to only one group. However, the statistical test-
ing in eGOn has taken multiple functions for genes in
consideration, why one and the same gene can be found
in several of the categories made by eGOn. Therefore the
groups in the tables do not correspond to the groups of
biological function made by eGOn.
RT-PCR
cDNA templates for RT-PCR were generated from five µg
of total RNA treated with DNase I (Roche Diagnostics
Scandinavia AB, Bromma, Sweden) in a reaction with 1 U
DNase I/µg RNA, 25 mM Tris (pH 8.0), 25 mM NaCl, 5
mM MgCl2 and 0.15 U rRNasin RNA inhibitor (Promega,
Madison, WI) for 25 min at 37°C. Single stranded cDNA
synthesis was made using PowerScript Reverse Tran-
scriptase (Clontech, CA) according to manufacturer's pro-
tocol. RT-PCR was performed using Taq Dynazyme
(Finnzymes, Espoo, Finland) under standard conditions
(1 × Dynazyme buffer, 0.2 mM dNTPs (Life Technolo-
gies), 0.5 U Taq Dynazyme, 1 µM of each specific primer
and 2 µl of cDNA) using a 4-min hot start at 94°C fol-
lowed by 30 cycles of 94°C for 45 sec, 59°C for 45 sec,
72°C for 1 min, followed by 10 min final extension at
72°C. Glucose-6-phosphate dehydrogenase (G6PD) was
co-amplified as an internal control in each reaction. PCR
products were analysed by 1.5% agarose gel electrophore-
sis (Sigma, St Louis, MO), and visualised using ethidium
bromide fluorescence. All primer pairs (Table 1) were
obtained from MedProbe (MedProbe AS, Oslo, Norway).
In situ hybridisation
Synthetic oligonucleotide probes (Table 1) were synthe-
sised and purified by reverse phase chromatography by
Medprobe. The oligonucleotides were labelled at the 3'
end with α-35S-dATP ((NEG034H) du Medical NEN,
Bruxelles, Belgium) using terminal-deoxynucleotidyl-
transferase TdT (Takara, Amersham Pharmacia Biotech,
Uppsala, Sweden) at 37°C for 1 hour and purified using
mini Quick Spin Oligo Columns (Roche Diagnostics
Scandinavia AB). The specific activities obtained ranged
from 1–4 × 109 cpm/µg oligonucleotide. 14 µm sections
were air-dried for one hour and covered with a hybridisa-
tion buffer containing 50% formamide, 4 × SSC, 1 × Den-
hardt's solution (0.02% polyvinyl-pyrrolidone, 0.02%
bovine serum albumin, and 0.02% Ficoll), 1% sarcosyl,
0.02 M phosphate buffer, 10% dextran sulphate (Amer-
sham Pharmacia Biotech), 500 µg/ml heat-denatured
salmon sperm DNA (Sigma) and 200 mM DTT (Amer-
sham Pharmacia Biotech), and 1 × 107 cpm/ml labelled
probe. The slides were incubated in a chamber humidified
with 4 × SSC and 50% formamide for 16–20 hours at
42°C. After hybridisation, the sections were rinsed in 1 ×
SSC at 40°C, 4 × 15 min in 1 × SSC at 55°C, 1 × SSC and
dH2O, 1 min each at room temperature followed by dehy-
dration with 60% and 95% ethanol. Sections were air-
dried and exposed on BioMax MR X-ray film (Eastman
Kodak, Rochester, NY) at room temperature for 6 days.
Immunohistochemistry
Frozen sections were air-dried, rehydrated in 1 × phos-
phate-buffered saline (PBS) and fixed in 4% buffered
paraformaldehyde for 7 min at room temperature, rinsed
in 1 × PBS, and blocked with normal goat serum (1:150)
in 1% BSA for 30 min at room temperature. Labelling was
made overnight with a monoclonal mouse anti rat CD-44
antibody 1:100 (Serotec, Oxford, UK), a mouse mono-
clonal anti rat MPIIIB101 (osteopontin) antibody 1:50
(Developmental Studies Hybridoma Bank, IA), or mouse
anti rat ED-1 antibody 1:1000 (Serotec) at 4°C. Sections
were rinsed in 1 × PBS and incubated with fluorescent or
indocarbocyanine (Cy3)-conjugated goat anti-mouse
1:1000 (Jackson Immunoresearch Lab. Inc, PA) or fluores-
cein isothiocyante (FITC)-conjugated goat anti mouse
1:150 (Jackson Immunoresearch Lab.) for 1 hour at room
temperature. Nuclear staining with Hoescht was per-
formed on slides with CD-44 immunolabelling. After
washing, the slides were mounted with glycerol:PBS. Eval-
uation of staining was performed by fluorescence micros-
copy with Leica filter cube N2.1 (excitation filter: 515–
560 nm, suppression filter edge wavelength: 590 nm) for
detection of Cy3-labelling and Leica filter cube L4 (excita-
tion filter: 450-490 nm, suppression filter edge wave-
length: 515–560 nm) for FITC labelling.
Photomicrographs for double labelling illustrations were
obtained by changing filter cube without altering section
position or focus.
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